Lubrizol recently announced that its LifeScience and Particle Sciences business have received Notice of Allowance for its device that delivers medication to the ear-drum.
“This latest patent is a clear-cut demonstration of our staff going beyond formulation to help our clients deliver a complete solution. it stems from work we did several years back and adds to the increasing pool of proprietary and public domain approaches Particle Sciences can offer its clients,” said Rob Lee, president of Particle Sciences. “This patent is aimed at providing targeted dosing to the tympanic membrane. We will be looking to partner with our clients on further development and utilization of this invention.”
Particle Sciences is FDA registered and DEA licensed and focuses on BCS II/III/IV molecules, biologics and highly potent compounds through different technologies like emulsions, gels, micro and nanoparticulates, drug-eluting devices, solid solutions, lyophilization and others.